Literature DB >> 35518819

Immediate reconstruction of segmental mandibular defects via tissue engineering.

Robert O Weiss1, Patrick E Wong1, Likith V Reddy1.   

Abstract

Ameloblastomas are benign, locally invasive odontogenic tumors that comprise approximately 1% of tumors within the jaws, with 66% located in the posterior mandible. If left untreated, these lesions can reach enormous size, resulting in considerable deformity and associated morbidity. Traditionally, defects >6 cm warranted a free-flap fibula transfer or iliac crest autogenous graft. Surgical treatment for the two presented cases included a large (>6 cm) mandibular segmental resection with immediate reconstruction via a tissue-engineering protocol that included bone morphogenetic protein (rhBMP-2), bone marrow aspirate concentrate, and cortical bone chips. Both patients had an uneventful postoperative course and healed satisfactorily. Established bone reconstruction determinants include bone volume, facial counter, esthetics, and restoration of functionality. Advances in tissue engineering provide a legitimate alternative while decreasing the risks, length of hospital stay, and postoperative morbidity.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Bone marrow aspirate; bone morphogenetic protein; mandibular defects; tissue engineering

Year:  2022        PMID: 35518819      PMCID: PMC9037396          DOI: 10.1080/08998280.2022.2035162

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

1.  Nonvascularized Bone Grafts for Reconstruction of Segmental Mandibular Defects: Is Length of Graft a Factor of Success?

Authors:  Andrei Marechek; Ahmad AlShare; Sean Pack; Catherine Demko; Faisal A Quereshy; Dale Baur
Journal:  J Oral Maxillofac Surg       Date:  2019-05-25       Impact factor: 1.895

Review 2.  Bone morphogenetic proteins in craniomaxillofacial surgery.

Authors:  Sarah D Davies; Mark W Ochs
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2010-02       Impact factor: 2.802

3.  Is immediate reconstruction of the mandible with nonvascularized bone graft following resection of benign pathology a viable treatment option?

Authors:  Thomas Schlieve; William Hull; Michael Miloro; Antonia Kolokythas
Journal:  J Oral Maxillofac Surg       Date:  2014-10-31       Impact factor: 1.895

4.  Immediate Transoral Allogeneic Bone Grafting for Large Mandibular Defects. Less Morbidity, More Bone. A Paradigm in Benign Tumor Mandibular Reconstruction?

Authors:  James C Melville; Nader N Nassari; Issa A Hanna; Jonathan W Shum; Mark E Wong; Simon Young
Journal:  J Oral Maxillofac Surg       Date:  2016-10-06       Impact factor: 1.895

5.  Allografts supercharged with bone-marrow-derived mesenchymal stem cells possess equivalent osteogenic capacity to that of autograft: a study with long-term follow-ups of human biopsies.

Authors:  Philippe Hernigou; Arnaud Dubory; François Roubineau; Yasuhiro Homma; Charles Henri Flouzat-Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2016-08-24       Impact factor: 3.075

Review 6.  Minimizing free flap donor-site morbidity.

Authors:  Brianna N Harris; Arnaud F Bewley
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2016-10       Impact factor: 2.064

7.  Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2).

Authors:  Alan S Herford; Philip J Boyne
Journal:  J Oral Maxillofac Surg       Date:  2008-04       Impact factor: 1.895

8.  Morbidity from bone harvest in major jaw reconstruction: a randomized trial comparing the lateral anterior and posterior approaches to the ilium.

Authors:  R E Marx; M J Morales
Journal:  J Oral Maxillofac Surg       Date:  1988-03       Impact factor: 1.895

9.  Donor leg morbidity and function after fibula free flap mandible reconstruction.

Authors:  J P Anthony; J D Rawnsley; P Benhaim; E F Ritter; S H Sadowsky; M I Singer
Journal:  Plast Reconstr Surg       Date:  1995-07       Impact factor: 4.730

10.  Is Reconstruction of Large Mandibular Defects Using Bioengineering Materials Effective?

Authors:  James C Melville; Huy Q Tran; Arsalan K Bhatti; Victoria Manon; Simon Young; Mark E Wong
Journal:  J Oral Maxillofac Surg       Date:  2019-12-02       Impact factor: 1.895

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.